Mumbai, India's pharmaceutical center , hosts several major players in the Carboplatin Active Pharmaceutical Ingredient (API) manufacturing landscape. A number of entities, including Cipla, are known to offer Carboplatin API (CAS No: 41575-94-4) adhering to stringent regulatory standards. These premier manufacturers cater to both domestic and expor